Polymerase Chain Reaction (PCR) is an analytical process very extensively used in Molecular Biology to make multiple copies of a DNA segments. PCR can generate millions of copy from one DNA segment. The Asia & Pacific Digital PCR and Real Time PCR (qPCR) market accounted for USD 676 million in 2018. It is expected to grow at a rate of 8.983% and is predicted to around USD 1.039 billion in 2023. In recent years the increasing demand for fast diagnostics, decrepit population, infectious and genetic disorders such as cancer, HIV, Hepatitis are some of pushing factors for the market growth. Rapid technological advancements are also one reason that has recently attracted investments in the market, but still a lot of growth is expected in this market. However, technical glitches and high initial cost of the dPCR & qPCR is a pulling force for the market.
The market is segmented by Product, by Technology, by Application, by End User & by Region. By Product the market is segregated into Consumables & Reagents, Instruments. By Technology the market is segregated as Quantitative PCR and Digital PCR. By Application the market is categorized as Tumors, Blood Testing, Pathogen Detection, research & forensics. By End User it is categorized as Hospitals, Research & Forensic centers, Pharmaceuticals & Bio- Technological Firms, Academic Institutions. By geography the market is segmented into India, China, Japan, South Korea, & Australia. Among them China & India are the two biggest market of this region as they are one of the fastest growing economies.
Recently, HDPCR multiplexing technology has been developed that combine’s proprietary data science algorithms that enrich the multiplex levels of common real time and digital PCR for detection of 5-50 target sites in a reaction at low cost. A profusion of bacterial allosteric transcription factors (STF) have been discovered to study about variety of very small molecules. A TF based nicked DNA segment-assisted signal transduction system (a TF-NAST) is used. The major key players in the market are Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.1 Consumables & Reagents
5..3 Instruments
5.1.4 Y-o-Y Growth Analysis, BY Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Produt
5.2 Technology
5.2.1 Introduction
5.2.2 Quantitative PCR
5.2.3 Digital PCR
5.2.3 Y-o-Y Growth Analysis, By Technology
5.2.4 Market Attractiveness Analysis, By Technology
5.2.5 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Tumor
5.3.2 Blood Testing
5.3.3 Pathogen Detection
5.3.4 Research & Forensic
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Research & Forensic centers
5.4.4 Pharmaceutical & Biotechnological centers
5.4.5 Academic Centers
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F Hoffman -La Roche Inc.
8.3 Bio-Rad Laboratories
8.4 Qiagen N.V.
8.5 Taraka Bio Inc.
8.6 Affymetrix Inc.
8.7 Agilent Technologies Inc.
8.8 Fluidigm Corporation
8.9 Danaher Corporation
8.10 Bector & Dickson Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
